Form 8-K - Current report:
SEC Accession No. 0001493152-25-001603
Filing Date
2025-01-10
Accepted
2025-01-10 11:31:52
Documents
14
Period of Report
2025-01-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41789
2 ex99-1.htm EX-99.1 15190
  Complete submission text file 0001493152-25-001603.txt   233916

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bixt-20250110.xsd EX-101.SCH 3027
4 XBRL LABEL FILE bixt-20250110_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bixt-20250110_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3559
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 25521496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)